Objective. The aim of this study was to evaluate the presence of digital lesions in very early diagnosis of SSc (VEDOSS) patients and its possible association with internal organ involvement.
Introduction
SSc is a major challenge for the rheumatologist, as its diagnosis is difficult in the very early/early phase of the disease [1] . For this reason, great interest is devoted today to patients with very early diagnosis of SSc (VEDOSS), when the degree of vasculopathy and fibrosis still have a minimal clinical impact [2] . The diagnosis of very early SSc is highly suspected in the presence of the so called red flags: RP, puffy fingers and ANA. The suspicion is then confirmed by the positivity of either ACA or anti-topo I positivity and/or a nailfold videocapillaroscopy (NVC) scleroderma pattern [2] .
Usually in established SSc, one of the main vascular complications is digital ulcers (DUs) [3] , which are a significant burden to SSc patients [4] . Therefore the problem of DUs has been considered as a clinical priority and randomized clinical trials have been designed to prevent and heal DUs [5] . In SSc, DUs appear early [6] , may significantly lower the patient's quality of life and may be a harbinger of a poorer prognosis [7, 8] . For this reason, the prompt identification and management of DUs is mandatory. The aim of the present study was to evaluate whether in VEDOSS patients digital lesions, and in particular DUs, could be detected early and whether their presence is associated with internal organ involvement [7] .
Methods
In the VEDOSS Clinic of the Department of Clinical and Experimental Medicine, Section of Rheumatology, Azienda Ospedaliero Universitaria Careggi (AOUC) of the University of Florence, 316 RP patients were enrolled in the VEDOSS study from March 2010 to May 2012. These patients are part of a larger cohort of patients involved in the multicentre VEDOSS study [9] : 110 patients were classified as VEDOSS according to the presence of preliminary criteria (RP, puffy fingers, ANA, plus NVC abnormalities and/or disease-specific antibodies) [2] . Other causes of digital vasculopathy, such as diabetes, cryoglobulinaemia, arterial hypertension and haematological diseases, were ruled out and smoking history was reported by 17% of the population. NVC was performed by trained physicians (C.B., G.L.) and images were classified into scleroderma patterns (early, active or late) according to the methodology and previously proposed classification [10] . In every patient, demographic data [age, sex, disease duration (defined as the time since RP onset)] were recorded during the first visit. The following signs and symptoms were investigated: presence of active DUs or a history of DUs as previously defined by Amanzi et al. [4] , oesophageal symptoms (heartburn and dysphagia), digital numbness (median nerve compression), dyspnoea, pitting scars, calcinosis and telangiectases and modified Rodnan skin score. All 110 patients were investigated for internal organ involvement, such as interstitial lung disease (ground glass, reticular or honeycombing pattern of pulmonary fibrosis), on chest high-resolution CT (HRCT), impairment of pulmonary function tests with/without a reduction in the diffusion capacity of carbon monoxide (DL CO ) and a dysfunctional oesophageal lower sphincter on oesophageal manometry (with basal low pressure <15 mmHg). Ethics approval was obtained from the Bioethical Committee of the AOUC of Florence, Italy. All participants provided written informed consent to participate in the study. Statistical analysis were performed using SPSS Statistics version 19 (IBM, Armonk, NY, USA) through chi-squared and Fisher's exact tests to test the association between binomial variables, while the MannWhitney U test was used to compare continuous variables. Table 1 .
Results

Clinical
VEDOSS patients with DUs
In the group of 25 patients with DUs and/or a history of DUs, ACA/anti-topo I were detected in 17 patients, while an early NVC pattern was detected in 19 and an active NVC scleroderma pattern was seen in 5. These two NVC SSc patterns were more frequently seen in patients with a DU (96%) compared with those without a history nor present DUs (66%), showing a statistically significant association with presence/history of DU (P < 0.01), in particular regarding the early scleroderma pattern (P < 0.01). Telangiectases were also associated with DUs (P < 0.05), as a possible other manifestation of generalized vasculopathy. There were trends of longer disease duration and higher frequency of anti-topo I antibodies in patients with DUs (P = 0.09 and P = 0.15, respectively).
Internal organ involvement
Patients with a history of or present DUs had a higher frequency of oesophageal manometry abnormalities only (21/25, 84%, P < 0.01). When patients with history of DUs and patients with active DUs were compared with patients without DUs, this association remained significant (P = 0.01 and P < 0.05, respectively). The whole cohort of 110 patients was then divided into four groups according to the presence of pulmonary involvement (pulmonary fibrosis or ground glass areas on chest HRCT with or without a reduction of DL CO <80%) and/or gastrointestinal involvement (dysfunctional oesophageal lower sphincter on manometry with basal low pressure <15 mmHg) as follows: patients without gastrointestinal or pulmonary involvement (23/110, 20.9%), patients with pulmonary involvement but without gastrointestinal disease (27/110, 24.5%), patients with gastrointestinal involvement but without pulmonary disease (30/110, 27.3%) and patients with gastrointestinal and pulmonary involvement (30/110, 27.3%) [11] . DUs were not seen in the group without internal involvement, while they were present in the second (4/27, 14.8%), third (13/30, 43.3%) and fourth groups (8/30, 26.6%). In addition, DUs showed a statistically significant association and correlation with gastrointestinal involvement (P < 0.01; see Table 2 ).
Discussion
It is well known that behind RP there frequently hides SSc and therefore a thorough internal organ investigation is mandatory [11] . This single-centre study identifies a large cohort of VEDOSS patients in which DUs and asymptomatic or subclinical involvement of the lung and/or gastrointestinal systems are already present. The results are in line with previous studies, confirming not only that early internal organ involvement can be detected in very early SSc patients [7, 12] , but also that its prevalence is comparable to what was reported for established SSc patients in a recent meta-analysis [13] . Furthermore, www.rheumatology.oxfordjournals.org our data show that DUs are already present in those VEDOSS patients who already show asymptomatic or subclinical oesophageal and/or lung involvement.
The detection of DUs in VEDOSS patients suggests that microvascular abnormalities are already prominent before the fibrotic features of SSc-related cutaneous, gastrointestinal and pulmonary involvement become symptomatic and clinically evident [12, 14] . In our VEDOSS population, a significant association was seen between DUs and anti-topo I autoantibodies, but not between DUs and ACA. This result is partially concordant with previous published data on established SSc patients [15, 16] . Regarding NVC, it is interesting to note that in our singlecentre study, no patient with a DU showed a late scleroderma pattern, which is more frequently associated with the presence of peripheral vascular lesions in established SSc patients [1719] . The evidence that a large number of VEDOSS patients develop internal organ involvement strongly suggests that these patients can be classified as already in an early phase of the disease, despite the (13) 1 (11) absence of skin tightness, as previously defined by our group [1] . The small number of VEDOSS patients without internal organ involvement may represent a limitation in this study. However, the fact that DUs are absent in patients classified as VEDOSS without organ involvement but present in patients with gastrointestinal and/or lung involvement suggests that DUs may be considered, in some cases, a sentinel sign for evolution from very early to early SSc with internal organ involvement (dysfunctional lower oesophageal sphincter, ground glass on HRCT, DL CO reduction on pulmonary function tests) [1] .
In conclusion, while RP remains the main clinical sentinel sign for the suspicion of very early SSc [2, 11] , our data suggest that in VEDOSS patients DUs may serve as a clinical sentinel sign of possible internal organ involvement, characterizing evolution to early SSc [1] . It remains to be evaluated how much the new ACR/European League Against Rheumatism (EULAR) criteria will modify the approach to the very early and early diagnosis of SSc now that fingertip ulcers have been added as a classification criterion [20] . It is interesting to note that 44% of the VEDOSS population already fulfil the new 2013 ACR/ EULAR classification criteria [9] and further evaluation of and attention to the presence of DUs could improve our ability to diagnose patients as SSc, especially for those patients without a positive disease-specific antibody. However, the VEDOSS study, characterized by diagnostic and not classification criteria, will help determine on a larger number of patients the real position of DUs in the identification of very early SSc and internal organ involvement.
Rheumatology key messages
. Digital ulcers are a major complication in SSc, even in very early and early disease. . The presence of digital ulcers in very early SSc patients should raise suspicion of internal organ involvement.
